BioMedSA’s Board of Directors approved 4 new memberships in March 2023: NewLife Medicals, Harness IP, Fukuda Denish, and Nixon Peabody.
NewLife Medicals (USA), Inc. supplies Reference Listed Drugs (RLDs) to large multinational companies, Clinical Research Organizations (CROs) and clinical trial sponsors. Their US FDA registered, GDP compliant warehouse provides storage & distribution facilities. Their storage and distribution solutions help pharmaceutical, nutraceutical, and biotechnology companies accelerate productivity through clinical development, manufacturing, drug development and commercialization process. Their US headquarters are in North Carolina.
Harness IP is an international Intellectual Property (IP) firm wth 100 IP attorneys covering diverse scientific technologies representing the world’s technology leaders. Harness IP’s team of trademark and patent attorneys serve clients in all areas of intellectual property law, including patents, trademarks, IP litigation, Patent Trial and Appeal Board (PTAB) Proceedings, trade secrets, due diligence investigations, and global IP management. Harness IP is Ranked a Best Law Firm by U.S. News & World Report.
Fukuda Denshi is a medical device company providing one-stop healthcare solutions, which span from prevention/testing, treatment, follow-up observation, and home medical care and rehabilitation. They specialize in patient monitoring devices that use AI to assist clinicians in delivering quick responses to patients’ overall needs, with a particular focus in cardiology. Their US headquarters are in Redmond, WA.
Nixon Peabody LLP (NP) is a full-service law firm with more than 600 attorneys, practicing throughout the United States and international markets from 15 locations across the world. The firm’s Intellectual Property (IP) practice group guides clients through the full IP lifecycle—from mining an organization’s research and development activities to capture and protect intellectual property to supporting the commercialization and branding of those assets, enforcing intellectual property rights, and defending against competitors. NP serves the life sciences industry, with particular depth in the pharmaceutical and biotechnology spaces.